Search for
Menu
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
About
+
Overview
Impact
Partners
Team
Entrepreneurs
+
Industries
Internship Program
Innovation Center
Mentors
Corporates
Capital
+
Rev1 Capital
Funds
Portfolio
Resources
+
Blog
Entrepreneur Toolkit
Jobs
Events
Get Started
Search for
Press Tag:
Clarametyx Biosciences
Categories
Categories
Filter by Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Company News
01/07/2025
Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Company News
11/19/2024
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Company News
10/24/2024
Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients
Top Tech Companies In Ohio To Watch in 2025
Company News, Rev1 News
10/14/2024
Top Tech Companies In Ohio To Watch in 2025
Nationwide Children’s infection-busting treatment gets pivotal tests
01/22/2024
Nationwide Children’s infection-busting treatment gets pivotal tests
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
01/05/2024
Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
06/01/2023
Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy
Startups to Watch: These Central Ohio Companies Could Take Off in 2023
Company News
01/06/2023
Startups to Watch: These Central Ohio Companies Could Take Off in 2023
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
05/31/2022
Otitis Media Market Size 2022 – Industry Share, Global Sales, Growth Rate with top companies – Blue Water Vaccines Inc, Ceolia Pharma Co Ltd, Clarametyx Biosciences Inc, Earnano LLC
Search for
All Blogs
Topics
Business
Capital
Getting Customers
Getting Funding
Getting Started
Inclusive Entrepreneurship
Market
Press
Product
Rev1 News
Startup Buzz
Team
The Hard Stuff
Uncategorized
VC Trends
1
2
Next »